- Reuters•2 hours ago
High U.S. share prices are pushing Lipper Award-winning equity fund managers into the shares of beaten-down healthcare companies, retailers and emerging-market stocks that they say offer a greater chance for outsized gains. Fund managers from Poplar Forest, Parnassus Investments and Brandes Investment Partners are among the 2017 Lipper Award winners who are concerned about the high valuation of the benchmark S&P 500 index. With a forward price-to-earnings ratio above 18, the index is at the high end of its historical range.
- GuruFocus.com•9 hours ago
These value investors love Allergan
- Investopedia•16 hours ago
The DEA has approved Syndros, an oral drug for chemotherapy and AIDs patients, as a Schedule II drug.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||233.00 - 237.20|
|52 Week Range||184.50 - 279.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.16|
|Dividend & Yield||2.80 (1.20%)|
|1y Target Est||N/A|